Qube Research & Technologies LTD Xtant Medical Holdings, Inc. Call Options Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding XTNT
# of Institutions
30Shares Held
90.3MCall Options Held
0Put Options Held
0-
Orbimed Advisors LLC San Diego, CA73.1MShares$38 Million1.11% of portfolio
-
Altium Capital Management LP New York, NY7.42MShares$3.86 Million2.49% of portfolio
-
Nantahala Capital Management, LLC New Canaan, CT3.58MShares$1.86 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.15MShares$1.12 Million0.0% of portfolio
-
Juniper Investment Company, LLC New York, NY1.32MShares$685,8500.39% of portfolio
About Xtant Medical Holdings, Inc.
- Ticker XTNT
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 108,226,000
- Market Cap $56.3M
- Description
- Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healin...